ZENAS BIOPHARMA INC (ZBIO) Stock Analyst Earnings Estimates
NASDAQ:ZBIO - Nasdaq - US98937L1052 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50M | -100.00% | 25.893M | |||
| EBITDA YoY % growth | -75.121M | -27.034M 64.01% | -147.191M -444.46% | -186.653M -26.81% | -222.458M -19.18% | |
| EBIT YoY % growth | -75.199M | -27.147M 63.90% | -149.727M -451.54% | -187.773M -25.41% | -200.401M -6.73% | |
| Operating Margin | N/A | -54.29% | N/A | N/A | -773.96% | |
| EPS YoY % growth | N/A | N/A | -7.47 | -3.95 47.17% | -3.71 5.93% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.02 | -1.10 | -1.16 | -1.08 78.46% | -1.16 -13.89% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -45.622M -84.96% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -43.199M -74.34% | -46.716M -69.40% | -49.776M -25.37% | -54.672M -33.40% | -59.16M -36.95% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -5.02 | -9.51 | 4.49 | 47.24% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.74% | 1.54% | -0.58% | 3.11% |
| Revenue | N/A | N/A | N/A | N/A |